- 全部删除
您的购物车当前为空
Ketanserin tartrate (KJK-945 tartrate) 是 5-HT2A 受体和α1-肾上腺素能受体拮抗剂,具有抗高血压活性,抑制血清素诱导的血管收缩和血小板活化,可用于研究系统性硬化症。

Ketanserin tartrate (KJK-945 tartrate) 是 5-HT2A 受体和α1-肾上腺素能受体拮抗剂,具有抗高血压活性,抑制血清素诱导的血管收缩和血小板活化,可用于研究系统性硬化症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 137 | In stock | |
| 10 mg | ¥ 186 | In stock | |
| 25 mg | ¥ 289 | In stock | |
| 50 mg | ¥ 413 | In stock | |
| 100 mg | ¥ 579 | In stock | |
| 500 mg | ¥ 1,380 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 216 | In stock |
Ketanserin tartrate 相关产品
| 产品描述 | Ketanserin tartrate (KJK-945 tartrate) is a 5-HT2A receptor and α1-adrenergic receptor antagonist with antihypertensive activity, inhibits serotonin-induced vasoconstriction and platelet activation, and can be used in the study of systemic sclerosis. |
| 靶点活性 | K+ channel (hERG):0.11 μM |
| 别名 | 酒石酸酮色林, KJK-945 tartrate, KJK945 tartrate, KJK 945 tartrate |
| 分子量 | 545.51 |
| 分子式 | C26H28FN3O9 |
| CAS No. | 83846-83-7 |
| Smiles | O[C@H]([C@@H](O)C(O)=O)C(O)=O.Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 |
| 密度 | 1.31g/cm3 |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 15 mg/mL (27.50 mM), Sonication is recommended. H2O: < 0.1 mg/mL (insoluble.) | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容